Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 503.00 GBp
Change Today 0.00 / 0.00%
Volume 362.0K
UDG On Other Exchanges
As of 8:53 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

udg healthcare plc (UDG) Snapshot

505.00 GBp
Previous Close
503.00 GBp
Day High
505.00 GBp
Day Low
498.00 GBp
52 Week High
05/15/15 - 551.50 GBp
52 Week Low
10/13/14 - 315.20 GBp
Market Cap
Average Volume 10 Days
0.49 GBp
Shares Outstanding
0.11 GBp
Dividend Yield
Current Stock Chart for UDG HEALTHCARE PLC (UDG)

Related News

No related news articles were found.

udg healthcare plc (UDG) Related Businessweek News

No Related Businessweek News Found

udg healthcare plc (UDG) Details

UDG Healthcare plc, together with its subsidiaries, provides supply chain, packaging, medical, regulatory, and sales and marketing services to healthcare manufacturers and pharmacies operating in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Supply Chain Services, Sharp Packaging Services, and Ashfield Commercial & Medical Services. The company offers integrated logistics and associated commercial services for pharmaceutical, biotech, and consumer companies in the areas of pharma wholesale, pre-wholesale comprising bulk distribution, and information services. It also provides clinical and commercial packaging, storage, logistics, and project management services to the pharmaceutical and biotech industries. In addition, the company offers outsourced services, including sales and marketing, healthcare communications, event management, medical affairs, and regulatory services to healthcare professionals and patients. Further, it provides healthcare communications and consultancy services; specialist healthcare and scientific public relations; clinical trials services; sales force effectiveness training services; and services in the travel health field, as well as distributes medical equipment and consumables, surgical products, laboratory equipment, and pharmaceutical products. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, Ireland.

7,477 Employees
Last Reported Date: 12/18/14
Founded in 1948

udg healthcare plc (UDG) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: €978.0K
Chief Financial Officer and Executive Directo...
Total Annual Compensation: €666.0K
Chief Operating Officer and Executive Directo...
Total Annual Compensation: €629.0K
Managing Director of Ashfield Commercial & Me...
Total Annual Compensation: €595.0K
Compensation as of Fiscal Year 2014.

udg healthcare plc (UDG) Key Developments

UDG Healthcare plc Announces Earnings Results for the Nine Months Ended June 30, 2015; Reiterates Earnings Guidance for the Year to September 30, 2015

UDG Healthcare plc announced earnings results for the nine months ended June 30, 2015. For the nine months, the company announced group revenues and adjusted operating profits are significantly ahead of the same period last year. Profit growth in the nine months to June has been driven by the strong performance of both the Sharp Packaging Services division (Sharp) and the Ashfield Commercial & Medical Services division (Ashfield). In addition, reported Group profitability has benefited from currency movements. The company reiterating guidance for constant currency adjusted diluted earnings per share (EPS) for the year to 30 September 2015 of between 7% and 9% ahead of last year. EPS growth is expected to be in the range of 18% to 20%, up from the previously guided range of 16% to 18%. The company expects an exceptional charge of approximately €15 million in 2015 (€11 million of which is a cash charge), at the upper end of previously guided range of €13 million to €15 million. The group also expects to deliver a good underlying cash flow performance for the year. When combined with modest debt levels relative to earnings and significant financing facilities, this continues to leave the Group well positioned to support its future growth objectives both organically and through acquisition. The company expects net debt at the end of the year will be somewhere in the region of €240 million to €250 million.

UDG Healthcare plc to Report Q3, 2015 Sales/Trading Statement Results on Aug 06, 2015

UDG Healthcare plc announced that they will report Q3, 2015 sales/trading statement results at 7:00 AM, GMT Standard Time on Aug 06, 2015

UDG Healthcare plc, Q3 2015 Sales/ Trading Statement Call, Aug 06, 2015

UDG Healthcare plc, Q3 2015 Sales/ Trading Statement Call, Aug 06, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UDG:LN 503.00 GBp 0.00

UDG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $83.69 USD +0.14
CMIC Holdings Co Ltd ¥1,606 JPY +42.00
EPS Holdings Inc ¥1,369 JPY +22.00
McKesson Corp $198.87 USD +0.98
View Industry Companies

Industry Analysis


Industry Average

Valuation UDG Industry Range
Price/Earnings 6.3x
Price/Sales 0.3x
Price/Book 1.3x
Price/Cash Flow 6.1x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UDG HEALTHCARE PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at